准分子激光原位角膜磨镶术后干眼：主要综述与最新进展
Dry Eye Post-Laser-Assisted In Situ Keratomileusis: Major Review and Latest Updates.
作者信息
Cohen Eyal, Spierer Oriel
机构信息
Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
J Ophthalmol. 2018 Jan 28;2018:4903831. doi: 10.1155/2018/4903831. eCollection 2018.
Abstract
Dry eye is one of the most common complications occurring after laser-assisted in situ keratomileusis (LASIK), with virtually all patients experiencing some degree of postoperative dry eye symptoms. Enhanced understanding of the pathophysiology and mechanism of dry eye development in addition to preoperative screening of patients who are prone to dry eye is essential for better patient satisfaction and for improving short-term visual outcome postoperatively. This article reviews the latest studies published on LASIK-associated dry eye, including epidemiology, pathophysiology, risk factors, preoperative assessment, and management.
摘要
干眼症是准分子原位角膜磨镶术（LASIK）后最常见的并发症之一，几乎所有患者都会出现一定程度的术后干眼症状。除了术前对易患干眼症的患者进行筛查外，加强对干眼症发病的病理生理学和机制的了解，对于提高患者满意度和改善术后短期视力结果至关重要。本文综述了关于LASIK相关性干眼症的最新研究，包括流行病学、病理生理学、危险因素、术前评估和治疗。
相似文献
1
Dry Eye Post-Laser-Assisted In Situ Keratomileusis: Major Review and Latest Updates.准分子激光原位角膜磨镶术后干眼：主要综述与最新进展
J Ophthalmol. 2018 Jan 28;2018:4903831. doi: 10.1155/2018/4903831. eCollection 2018.
2
Dry eye after laser in-situ keratomileusis.准分子激光原位角膜磨镶术后干眼
Semin Ophthalmol. 2014 Sep-Nov;29(5-6):358-62. doi: 10.3109/08820538.2014.962663.
3
Post-LASIK dry eye.准分子激光原位角膜磨镶术后干眼症
Expert Rev Ophthalmol. 2011 Oct;6(5):575-582. doi: 10.1586/eop.11.56.
4
Laser-assisted in situ keratomileusis for patients with dry eye.用于干眼症患者的准分子激光原位角膜磨镶术
Arch Ophthalmol. 2002 Aug;120(8):1024-8. doi: 10.1001/archopht.120.8.1024.
5
Allergic complications with laser-assisted in-situ keratomileusis.激光辅助原位角膜磨镶术的过敏并发症。
Curr Opin Allergy Clin Immunol. 2011 Oct;11(5):483-91. doi: 10.1097/ACI.0b013e32834a4e01.
6
Recent advances in laser in situ keratomileusis-associated dry eye.准分子原位角膜磨镶术相关干眼的最新进展
Clin Exp Optom. 2016 Mar;99(2):107-12. doi: 10.1111/cxo.12361.
7
Referrals to the Wills Eye Institute Cornea Service after laser in situ keratomileusis: reasons for patient dissatisfaction.准分子原位角膜磨镶术后转诊至威尔斯眼科研究所角膜服务中心：患者不满意的原因
J Cataract Refract Surg. 2008 Jan;34(1):32-9. doi: 10.1016/j.jcrs.2007.08.028.
8
Effect of laser in situ keratomileusis on tear stability.准分子原位角膜磨镶术对泪液稳定性的影响。
Ophthalmology. 2000 Dec;107(12):2131-5. doi: 10.1016/s0161-6420(00)00388-2.
9
Dry Eye After LASIK.LASIK 术后干眼
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES109-DES115. doi: 10.1167/iovs.17-23538.
10
Prospective, randomized comparison of self-reported postoperative dry eye and visual fluctuation in LASIK and photorefractive keratectomy.前瞻性、随机对照研究 LASIK 和光折射性角膜切削术术后干眼和视觉波动的自我报告比较。
Ophthalmology. 2012 Nov;119(11):2220-4. doi: 10.1016/j.ophtha.2012.06.013. Epub 2012 Aug 11.
引用本文的文献
1
The Effect of Preoperative Dry Eye Disease on the Outcome of Second (Visumax 800) Generation Keratorefractive Lenticule Extraction Surgery.术前干眼症对第二代（Visumax 800）角膜屈光透镜切除术结果的影响。
In Vivo. 2025 Jul-Aug;39(4):2144-2153. doi: 10.21873/invivo.14010.
2
Applications of Diquafosol Sodium in Ophthalmology: A Comprehensive Review of Therapeutic Utility.地夸磷索钠在眼科的应用：治疗效用的全面综述
Life (Basel). 2025 Mar 17;15(3):484. doi: 10.3390/life15030484.
3
Varenicline Solution Nasal Spray 0.03 Mg for the Treatment of Dry Eye Disease Following Photorefractive Keratectomy.伐尼克兰溶液鼻喷雾剂0.03毫克用于治疗准分子激光原位角膜磨镶术后干眼症。
Clin Ophthalmol. 2024 Oct 5;18:2777-2784. doi: 10.2147/OPTH.S474747. eCollection 2024.
4
Varenicline Solution Nasal Spray for the Treatment of Dry Eye Disease Following LASIK.用于治疗准分子激光原位角膜磨镶术后干眼症的酒石酸伐尼克兰溶液鼻喷雾剂
Ophthalmol Ther. 2024 Jun;13(6):1693-1701. doi: 10.1007/s40123-024-00949-4. Epub 2024 Apr 25.
5
Patient-Reported Dry Eye Outcomes After Myopic Femtosecond-LASIK: A 6-Month Prospective Analysis.近视飞秒激光原位角膜磨镶术后患者报告的干眼结局：一项为期6个月的前瞻性分析。
Clin Ophthalmol. 2023 Jul 25;17:2141-2147. doi: 10.2147/OPTH.S421369. eCollection 2023.
6
Post-LASIK dry eye disease: A comprehensive review of management and current treatment options.准分子激光原位角膜磨镶术后干眼症：管理与当前治疗选择的综合综述
Front Med (Lausanne). 2023 Apr 11;10:1057685. doi: 10.3389/fmed.2023.1057685. eCollection 2023.
7
Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery.激光角膜屈光手术后干眼的泪液血管活性肠肽作用。
BMC Ophthalmol. 2023 Apr 20;23(1):167. doi: 10.1186/s12886-023-02857-w.
8
Refractive surgery and dry eye - An update.屈光手术与干眼：最新进展。
Indian J Ophthalmol. 2023 Apr;71(4):1105-1114. doi: 10.4103/IJO.IJO_3406_22.
9
The Effect of Meibomian Gland Dysfunction on Laser-Assisted In Situ Keratomileusis in Asymptomatic Patients.睑板腺功能障碍对无症状患者准分子原位角膜磨镶术的影响。
Ophthalmol Ther. 2023 Feb;12(1):281-291. doi: 10.1007/s40123-022-00610-y. Epub 2022 Nov 8.
10
Management of Post-LASIK Dry Eye with Intense Pulsed Light in Combination with 0.1% Sodium Hyaluronate and Heated Eye Mask.强脉冲光联合0.1%透明质酸钠及加热眼罩治疗准分子激光原位角膜磨镶术后干眼
Ophthalmol Ther. 2022 Feb;11(1):161-176. doi: 10.1007/s40123-021-00418-2. Epub 2021 Nov 6.
本文引用的文献
1
TFOS DEWS II Management and Therapy Report.TFOS DEWS II 管理和治疗报告。
Ocul Surf. 2017 Jul;15(3):575-628. doi: 10.1016/j.jtos.2017.05.006. Epub 2017 Jul 20.
2
Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial.0.1%环孢素A阳离子乳剂治疗重度干眼病的疗效和安全性：一项多中心随机试验
Eur J Ophthalmol. 2016 Jun 10;26(4):287-96. doi: 10.5301/ejo.5000779. Epub 2016 Apr 7.
3
Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes.准分子激光原位角膜磨镶术（LASIK）后干眼症患者泪液基质金属蛋白酶9升高的即时检测评估
Br J Ophthalmol. 2016 Sep;100(9):1188-91. doi: 10.1136/bjophthalmol-2015-307607. Epub 2015 Dec 18.
4
Structural and functional changes in corneal innervation after laser in situ keratomileusis and their relationship with dry eye.准分子原位角膜磨镶术后角膜神经支配的结构和功能变化及其与干眼的关系。
Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):2029-39. doi: 10.1007/s00417-015-3120-1. Epub 2015 Aug 11.
5
Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes.3% 地夸磷索滴眼液治疗干眼症的临床应用
Clin Ophthalmol. 2015 May 15;9:865-72. doi: 10.2147/OPTH.S69486. eCollection 2015.
6
Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.使用0.03%他克莫司滴眼液治疗干燥综合征干眼：前瞻性双盲随机研究。
Cont Lens Anterior Eye. 2015 Oct;38(5):373-8. doi: 10.1016/j.clae.2015.04.004. Epub 2015 May 5.
7
Variability of Tear Osmolarity in Patients With Dry Eye.干眼症患者泪液渗透压的变异性
JAMA Ophthalmol. 2015 Jun;133(6):662-7. doi: 10.1001/jamaophthalmol.2015.0429.
8
Tear menisci and corneal subbasal nerve density in patients after laser in situ keratomileusis.准分子原位角膜磨镶术后患者的泪液半月板与角膜基底膜下神经密度
Eye Contact Lens. 2015 Jan;41(1):51-7. doi: 10.1097/ICL.0000000000000062.
9
Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation.THBS1 基因多态性与屈光手术后慢性眼表炎症有关。
Ophthalmology. 2014 Jul;121(7):1389-97. doi: 10.1016/j.ophtha.2014.01.033. Epub 2014 Mar 27.
10
Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops.用 0.03%他克莫司滴眼液治疗移植物抗宿主病相关难治性干眼。
J Ocul Pharmacol Ther. 2013 Oct;29(8):776-83. doi: 10.1089/jop.2012.0265. Epub 2013 Aug 15.
Zotero 插件